Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CalciMedica, Inc. - Common Stock (NQ: CALC )

3.700 +0.190 (+5.41%)
Streaming Delayed Price Updated: 9:44 AM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CalciMedica, Inc. - Common Stock

CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
From CalciMedica
Via GlobeNewswire
CalciMedica Announces Relisting on Nasdaq
From CalciMedica
Via GlobeNewswire
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
From CalciMedica
Via GlobeNewswire
CalciMedica Expands Executive Team with New Appointments
Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical Development 
From CalciMedica
Via GlobeNewswire
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.